Company profile · Sponsor
Mylan
Mylan dura GmbH
- Pipeline
- 4
- Drugs
- 0
- Patents
- 0
Quick answer
Mylan (E91CC8A) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..
Company facts
Pipeline (4)
Search pipeline →-
SAMYR 400 mg compresse gastroresistenti, Samyr placebo (same excipient as SAMYR)
Mylan
Major Depression Disorder
1 trial -
Sodio Cloruro Fresenius Kabi Italia 0,9%, solvente per uso parenterale, Samyr placebo (saline solution), SAMYR 400 mg/5ml polvere e solvente per soluzione iniettabile
Mylan
Major Depression Disorders
1 trial -
MR-130A-01
Mylan
Investigation of maintenance of ovulation inhibition after intentional application errors for indication of contraception in healthy subjects
1 trial -
A bioavailability study of epinephrine following a single dose of emergency response auto-injector in comparison to epinephrine injection into muscle via syringe in healthy adults.
Mylan
Allergic reactions (Type 1), including anaphylaxis, idiopathic anaphylaxis or exercise-induced anaphylaxis
1 trial
Frequently asked questions
What is Mylan?
Mylan (E91CC8A) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..
What pipeline programs does Mylan sponsor?
We track 4 ClinicalTrials.gov-linked programs for Mylan, including SAMYR 400 mg compresse gastroresistenti, Samyr placebo (same excipient as SAMYR) and 3 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does Mylan company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.